Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$108.03 USD
-1.13 (-1.04%)
Updated Dec 6, 2024 04:00 PM ET
After-Market: $108.00 -0.03 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth D Momentum C VGM
Price, Consensus and EPS Surprise
ZBH 108.03 -1.13(-1.04%)
Will ZBH be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for ZBH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ZBH
Perrigo (PRGO) Up 5.6% Since Last Earnings Report: Can It Continue?
Reasons to Retain ZBH Stock in Your Portfolio for Now
ZBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
ZBH Stock Might Rise Following FDA Nod for Knee Implant Component
Why Is Zimmer (ZBH) Up 4.8% Since Last Earnings Report?
ZBH Stock Gains From FDA Nod for Oxford Cementless Partial Knee
Other News for ZBH
13 Healthcare Sector Stocks With Healthy Valuation
Zimmer gets FDA okay for Persona SoluTion PPS Femur device
Zimmer announces FDA clearance of Persona SoluTion Porous Plasma Spray Femur
Zimmer announces FDA clearance of Persona SoluTion Porous Plasma Spray Femur
Zimmer Biomet assumed with an Equal Weight at Morgan Stanley